Torthaí cuardaigh - Lansdorp-Vogelaar, Iris
- 1 - 20 toradh as 113 á dtaispeáint
- Téigh chuig an gcéad leathanach eile
-
1
Cost-effectiveness of screening and treating H. Pylori for gastric cancer prevention de réir Lansdorp-Vogelaar, Iris, Sharp, Linda
Foilsithe / Cruthaithe 2013Téacs -
2
Cost-effectiveness of colorectal cancer screening – an overview de réir Lansdorp-Vogelaar, Iris, Knudsen, Amy, Brenner, Hermann
Foilsithe / Cruthaithe 2010Téacs -
3
Cost-effectiveness of Colorectal Cancer Screening de réir Lansdorp-Vogelaar, Iris, Knudsen, Amy B., Brenner, Hermann
Foilsithe / Cruthaithe 2011Téacs -
4
-
5
Colorectal Cancer Screening in the Novel Coronavirus Disease-2019 Era de réir Dekker, Evelien, Chiu, Han-Mo, Lansdorp-Vogelaar, Iris
Foilsithe / Cruthaithe 2020Téacs -
6
Trends in Incidence and Stage at Diagnosis of Colorectal Cancer in Adults Aged 40 Through 49 Years, 1975-2015 de réir Meester, Reinier G. S., Mannalithara, Ajitha, Lansdorp-Vogelaar, Iris, Ladabaum, Uri
Foilsithe / Cruthaithe 2019Téacs -
7
Development of new non-invasive tests for colorectal cancer screening: The relevance of information on adenoma detection de réir Haug, Ulrike, Knudsen, Amy B., Lansdorp-Vogelaar, Iris, Kuntz, Karen M.
Foilsithe / Cruthaithe 2014Téacs -
8
-
9
Comparative Success and cost-effectiveness of mailed-out faecal immunochemical tests versus collection at the general practitioner de réir Peterse, Elisabeth F P, Osoro, Caroline B, Bardou, Marc, Lansdorp-Vogelaar, Iris
Foilsithe / Cruthaithe 2021Téacs -
10
Impact of assumptions on future costs, disutility and mortality in cost-effectiveness analysis; a model exploration de réir Omidvari, Amir-Houshang, Lansdorp-Vogelaar, Iris, de Koning, Harry J., Meester, Reinier G. S.
Foilsithe / Cruthaithe 2021Téacs -
11
Cost-effectiveness analysis of colorectal cancer screening in a low incidence country: The case of Saudi Arabia de réir Naber, Steffie K., Almadi, Majid A., Guyatt, Gordon, Xie, Feng, Lansdorp-Vogelaar, Iris
Foilsithe / Cruthaithe 2021Téacs -
12
A Novel Hypothesis on the Sensitivity of FOBT: Results of a Joint Analysis of Three Randomized Controlled Trials de réir Lansdorp-Vogelaar, Iris, van Ballegooijen, Marjolein, Boer, Rob, Zauber, Ann, Habbema, J. Dik F.
Foilsithe / Cruthaithe 2009Téacs -
13
Optimising the expansion of the National Bowel Cancer Screening Program de réir Cenin, Dayna R, St John, James, Slevin, Terry, Ledger, Melissa J, Lansdorp-Vogelaar, Iris
Foilsithe / Cruthaithe 2014Téacs -
14
-
15
-
16
COVID-19 and Cancer Global Modelling Consortium (CCGMC): A global reference to inform national recovery strategies de réir Soerjomataram, Isabelle, Bray, Freddie, Lansdorp-Vogelaar, Iris, Ginsburg, Ophira, Rahal, Rami, Sullivan, Richard, Canfell, Karen
Foilsithe / Cruthaithe 2022Téacs -
17
Effect of Rising Chemotherapy Costs on the Cost Savings of Colorectal Cancer Screening de réir Lansdorp-Vogelaar, Iris, van Ballegooijen, Marjolein, Zauber, Ann G., Habbema, J. Dik F., Kuipers, Ernst J.
Foilsithe / Cruthaithe 2009Téacs -
18
At what costs will screening with CT Colonography be competitive? A cost-effectiveness approach de réir Lansdorp-Vogelaar, Iris, van Ballegooijen, Marjolein, Zauber, Ann, Boer, Rob, Wilschut, Janneke, Dik, J., Habbema, F.
Foilsithe / Cruthaithe 2009Téacs -
19
-
20
An Evolutionary Algorithm to Personalize Stool-Based Colorectal Cancer Screening de réir van Duuren, Luuk A., Ozik, Jonathan, Spliet, Remy, Collier, Nicholson T., Lansdorp-Vogelaar, Iris, Meester, Reinier G. S.
Foilsithe / Cruthaithe 2022Téacs